As of June 21, 2025, Bachem Holding AG (BANB.SW) reports a Net Margin of 19.87%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Bachem Holding AG's Net Margin
Over recent years, Bachem Holding AG's Net Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 19.87% |
| 2023-12-31 | 19.38% |
| 2022-12-31 | 18.93% |
| 2021-12-31 | 22.79% |
| 2020-12-31 | 19.42% |
This steady improvement highlights how Bachem Holding AG manages its overall profitability and cost control over time.
Comparing Bachem Holding AG's Net Margin to Peers
To better understand Bachem Holding AG's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Bachem Holding AG (BANB.SW) | 19.87% |
| PureTech Health PLC (PRTC.L) | 1108.33% |
| Chemometec A/S (CHEMM.CO) | 33.41% |
| Genovis AB (GENO.ST) | 25.25% |
| Eurofins-Cerep SA (ALECR.PA) | 17.36% |
| Biotage AB (BIOT.ST) | 13.81% |
Compared to its competitors, Bachem Holding AG's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.